Key terms
About AGEN
Agenus, Inc. is a clinical-stage company, which engages in the development and commercialization of technologies to treat cancers and infectious diseases. Its product pipeline includes Balstilimab, Zalifrelimab, AGEN1181, AGEN1327, AGEN2373, AGENt-797 and AGEN1777. The company was founded by Garo H. Armen and Pramod K. Srivastava on March 31, 1994 and is headquartered in Lexington, MA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest AGEN news
Apr 17
6:52am ET
Agenus price target lowered to $35 from $120 at Baird
Apr 15
10:45am ET
Biotech Alert: Searches spiking for these stocks today
Apr 12
7:34am ET
Agenus announces updated results from BOT/BAL combination therapy trial
Apr 11
7:50pm ET
Agenus trading halted, news pending
Apr 05
4:31pm ET
Agenus announces 1-for-20 reverse stock split
Mar 19
2:30am ET
Analysts’ Top Healthcare Picks: Compass Therapeutics (CMPX), Guardant Health (GH)
Mar 18
8:52am ET
Agenus price target lowered to $5 from $6 at B. Riley
Mar 16
2:01am ET
Agenus Inc.’s Future at Risk: Concerns Over Financial Health and Operational Viability
Mar 15
12:45pm ET
Buy Rating Affirmed for Agenus Amidst Promising Cancer Immunotherapy Developments and Strategic Financial Moves
Mar 14
11:15am ET
Agenus Poised for Growth: Anticipated BLA Filing and Promising Clinical Data Underpin Buy Rating
Mar 11
8:00am ET
Options Volatility and Implied Earnings Moves This Week, March 11 – March 15, 2024
Mar 06
2:35pm ET
Agenus’s Promising Botensilimab Leads to Buy Rating from Analyst Mayank Mamtani
Feb 15
8:12am ET
Agenus Announces 1:20 Reverse Stock Split Effective February 2024
Feb 15
7:19am ET
Ginkgo Bioworks and Agenus subsidiary awarded MCDC vaccine contract
Jan 25
8:00am ET
Analysts Are Bullish on Top Healthcare Stocks: Agenus (AGEN), Zivo Bioscience (ZIVO)
Jan 22
4:00pm ET
Analysts Offer Insights on Healthcare Companies: Agenus (AGEN), Regeneron (REGN) and Warby Parker (WRBY)
Jan 22
10:03am ET
Agenus: Botensilimab/balstilimab data shows tumor shrinkage, biomarker response
No recent press releases are available for AGEN
AGEN Financials
Key terms
Ad Feedback
AGEN Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
AGEN Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range